The Recall Desk

Manufacturer

AAA Pharmaceutical, Inc.

4 recalls in our database name AAA Pharmaceutical, Inc. as the manufacturing or recalling firm.

What the numbers show

Total
4
Critical
0
Severe
2
Most recent
2020-03-11

Of the 4 recalls from AAA Pharmaceutical, Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 2 (50%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–4 of 4

  • LowFDA (Drugs)·D-0868-2020·2020-03-11

    AAA Pharmaceutical Recalls Fexofenadine Tablets for Labeling Errors

    AAA Pharmaceutical, Inc. is recalling specific lots of Discount Drug Mart Fexofenadine Hydrochloride Tablets due to incorrect or missing lot and expiration dates.

    Product
    Discount Drug Mart, Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 mg /Antihistamine, Indoor/Outdoor Allergies, 24 Hour, a) 30 tablets per bottle, NDC 53943-192-04, UPC Code 0-93351-03069-7; b) 45 tablets per bottle, NDC 53943-192-06, UPC Code 0-93351-03070-3, Distribute
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0645-2020·2020-01-15

    AAA Pharmaceutical Recalls Ranitidine Tablets Due to NDMA Impurity

    AAA Pharmaceutical is recalling Ranitidine 150 mg tablets because the active ingredient contained the impurity N-nitrosodimethylamine (NDMA).

    Product
    Ranitidine 150 mg tablets, 24 count bottles, NDC 37808-196-01.
    Category
    Drug
    Distribution
    0 states
  • SevereFDA (Drugs)·D-0646-2020·2020-01-15

    AAA Pharmaceutical Recalls Ranitidine Tablets Due to NDMA Impurity

    AAA Pharmaceutical is recalling specific lots of Ranitidine 150 mg tablets because the active ingredient contained the impurity N-nitrosodimethylamine (NDMA).

    Product
    Ranitidine 150 mg tablets, 130 count bottles, NDC 37808-196-04.
    Category
    Drug
    Distribution
    0 states
  • LowFDA (Drugs)·D-1585-2019·2019-08-14

    Smart Sense Aspirin Recalled for Incorrect Expiration Date Labeling

    AAA Pharmaceutical is recalling Smart Sense Regular Strength Aspirin Tablets due to an incorrect expiration date on the label.

    Product
    Smart Sense Regular Strength Aspirin Tablets, 325 mg packed in a) 100 count UPC 8-8397-38781-6 and b) 500 count UPC 8-83967-38786-1 bottles, Distributed by: Kmart Corporation Hoffman Estates, IL 60179
    Category
    Drug
    Distribution
    1 state